2 months Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. Investor's Business Daily

   X     

2 months Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

   X     

2 months Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily

   X     

2 months Why Amgen (AMGN) is a Top Growth Stock for the Long-Term Zacks

   X     

2 months Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

   X     

3 months Here’s Why Amgen (AMGN) is a Strong Value Stock Zacks

   X     

3 months Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

   X     

3 months The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

   X     

3 months Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha

   X     

3 months The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem Zacks

   X     

3 months Top Stock Reports for Amgen, Eaton & Enzo Biochem Zacks

   X     

3 months Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

   X     

3 months Amgen Stock Falls 12% in a Month: Should You Buy the Dip? Zacks

   X     

3 months Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal

   X     

3 months Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

3 months Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? Yahoo Finance

   X     

3 months AMGN Stock Down Despite Strong Data From Obesity Drug Study Zacks

   X     

3 months Amgen’s Phase 2 Results Were Not Bad, Don’t Let Mr. Market Fool You Seeking Alpha

   X     

3 months Amgen: Checks All The Wrong Boxes Seeking Alpha

   X     

3 months Final Trade: JWN, IWM, GCO, AMGN YouTube

   X     

3 months Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond YouTube

   X     

3 months Amgen stock sinks as weightloss drug fails to impress FXStreet

   X     

3 months Amgen: MariTide Underwhelms, But There Are Ways To Win Seeking Alpha

   X     

3 months Chart of the Day: Amgen YouTube

   X     

3 months Cramer’s Stop Trading: Amgen YouTube

   X     

3 months Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know. Yahoo Finance

   X     

3 months Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily

   X     

3 months Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know. Yahoo Finance

   X     

3 months Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau YouTube

   X     

3 months These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance

   X     

3 months Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks

   X     

3 months Amgen Sells Off: Keep Calm And Buy The Dip Seeking Alpha

   X     

3 months Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

3 months Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare FXStreet

   X     

3 months Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate Zacks

   X     

3 months Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript) Seeking Alpha

   X     

3 months Trade Tracker: Joe Terranova sells Amgen and buys XBI YouTube

   X     

3 months Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily

   X     

3 months Amgen dismisses bone density concerns related to its new weight-loss drug Investing.com

   X     

3 months Amgen sinks as Cantor flags issues with obesity drug YouTube

   X     

3 months Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC

   X     

3 months Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity Shot Investor's Business Daily

   X     

4 months Big Pharma’s Obesity Bonanza Faces New Tests The Wall Street Journal

   X     

4 months Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market Seeking Alpha

   X     

4 months Analyst Report: AMGEN Inc. Yahoo Finance

   X     

4 months Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHC Yahoo Finance

   X     

4 months Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

4 months Amgen Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

   X     

4 months Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO Investor's Business Daily

   X     

4 months Amgen beats Q3 earnings estimates, raises full-year guidance Investing.com

   X